Cytonics Corporation
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Evaluation of CYT-108, A Recombinant Protease Inhibitor, for Treatment of Mild To Moderate Primary Osteoarthritis Of The Knee (NCT06263270) | Cytonics Corporation | 2024-06-01 |
| APIC-CF Therapy for Mild to Moderate Osteoarthritis of the Knee (NCT02210468) | Cytonics Corporation | 2015-05-01 |
| Safety and Efficacy Study of APIC-PRP in Non-healing Diabetic Foot Ulcers (NCT02209662) | Cytonics Corporation | 2014-10-01 |
Track Cytonics Corporation automatically
Every clearance here is in the API, with alerts when new ones post.